Effect of Foam and Liquid Bleomycin in the Management of Venous Malformations in Head and Neck Region. A Comparative Study

1- Derby L.D. AND Low D.W.: Laser treatment of facial
venous vascular malformations. Ann. Plast. Surg., 38:
371-8, 1997.
2- Mahady K., Thust S., Berkeley R., Stuart S., Barnacle A.,
Robertson F. and Mankad K.: Vascular anomalies of the
head and neck in children. Quant. Imaging Med. Surg.,
Dec., 5 (6): 886-97, 2015.
3- Mulliken J.B. and Glowacki J.: Hemangiomas and vascular
malformations in infants and children: A classification
based on endothelial characteristics. Plast. Reconstr. Surg.,
69: 412Y420, 1982.
4- ISSVA classification for vascular anomalies© (approved
at the International Society for the Study of Vascular
Anomalies workshop, Melbourne, April 2014). Available
from URL: issva.org/classification (accessed October
2016).
5- Lee B.B.: Critical issues on the management of congenital
vascular malformation. Ann. Vasc. Surg., 18: 380-92,
2004.
6- Belov S.: Anatomopathological classification of congenital
vascular defects. Semin. Vasc. Surg., 6 (4): 219-24, 1993.
7- Belov S.T.: Classification of congenital vascular defects.
Int. Angiol., 9: 141-6, 1990.
8- Deveikis J.P.: Percutaneous ethanol sclerotherapy for
vascular malformations in the head and neck. Arch. Facial
Plast. Surg., 7: 322-5, 2005.
9- Greene A.K. and Alomari A.I.: Management of venous
malformations. Clin. Plast. Surg., 38: 83-93, 2011.
10- Sachin K., Rashmi S., Manish S., et al.: Haemangiomas
and venous malformations of the head and neck: A retrospective
analysis of endovascular management in 358
patients. Indian J. Plast. Surg., 109-16, 2013.
11- Legiehn G.M. and Heran M.K.: Classification, diagnosis,
and interventional radiologic management of vascular
malformations. Orthop. Clin. North Am., 37: 435-74,
2006.
12- Legiehn G.M. and Heran M.K.: Venous malformations:
Classification, development, diagnosis, and interventional
radiologic management. Radiol. Clin. North Am., 46:
545-97, 2008.
13- Zheng J.W., Yang X.J., Wang Y.A., et al.: Intralesional
injection of Pingyangmycin for vascular malformations
in oral and maxillofacial regions: An evaluation of 297
consecutive patients. Oral Oncol., 45: 872-6, 2009.
14- Yang Y., Sun M., Ma Q., et al.: Bleomycin A5 sclerotherapy
for cervico-facial lymphatic malformations. J. Vasc.
Surgery, 53: 150-5, 2011.
15- Yang Y., Sun M., Cheng X., et al.: Bleomycin A5 plus
dexamethasone for control of growth in infantile parotid
hemangiomas. Oral Surg. Oral Med. Oral Pathol. Oral
Radiol Endod., 108: 62-9, 2009.
16- Muir T., Kirsten M., Fourie P., et al.: Intralesional Bleomycin
Injection (IBI) treatment for haemangiomas and
congenital vascularmal formations. Pediatr. Surg. Int.,
19: 766-73, 2004.
17- Zhao J.H., Zhang W.F. and Zhao Y.F.: Sclerotherapy of
oral and facial venous Malformations with use of pingyangmycin
and/or sodium morrhuate. Int. J. Oral Maxillo.
Fac. Surg., 33: 463-6, 2004.
18- Zhi K., Wen Y., Li L., et al.: The role of intralesional
Pingyangmycinin the treatment of venous malformation
official and maxillary region. Int. J. Pediatr. Otorhinolaryngol.,
72: 593-7, 2008.
19- Seigel R.D. and Schiffman F.J.: Systemic toxicity following
intracavitatory administration of bleomycin, Chest, 98
(2): 507, 1990.
20- Luce J.K.: Clinical trial of bleomycin in solid tumours
and lymphomas. Proc. Am. Assoc. Cancer Res., 10: 38,
1969.
21- Tessari L., Cavezzi A. and Frullini A.: Preliminary experience
with a new sclerosing foam in the treatment of
varicose veins. Dermatol. Surg., 27: 58-60, 2001.
22- Yamaki T., Nozaki M., Fujiwara O., et al.: Duplex-guided
foam sclerotherapy for the treatment of the symptomatic
venous malformations of the face. Dermatol. Surg., 28:
619-22, 2002.
23- Cabrera J., Cabrera J. Jr., Garcia-Olmedo A. and Redondo
P.: Treatment of venous malformations with sclerosant in
microform foam. Arch. Dermatol., 139: 1409-16, 2003.
24- Pascarella L., Bergan J.J., Yamada C. and Mekenas L.:
Venous angiomata: Treatment with sclerosant foam. Ann.
Vasc. Surg., 19: 457-64, 2005.
25- Bergan J., Pascarella L. and Mekenas L.: Venous disorders:
Treatment with sclerosant foam. J. Cardiovasc. Surg., 47:
115-24, 2005.
26- Yamaki T., Nozaki M., Sakurai H., et al.: Prospective
randomized efficacy of ultrasoundguided foam sclerotherapy
compared with ultrasound-guided liquid sclerotherapy
in the treatment of symptomatic venous malformations,
Journal of Vascular Surgery, March, 578-84, 2008.
27- Ul Haq F., Mitchell S.E., Tekes A. and Weiss C.R.:
Bleomycin foam treatment of venous malformations: A
promising agent for effective treatment with minimal
swelling. J. Vasc. Interv. Radiol., 26: 1484-93, 2015.
28- Azene E., Mitchell S., Radvany M., et al.: Foamed Bleomycin
Sclerosis of Airway Venous Malformations: The
Role of Interspecialty Collaboration Laryngoscope, 126:
2726-32, 2016.
29- Berenstein A.: E-059 Bleomycin Sclerotherapy for Eyelid
Venous Malformations as an Alternative to Surgery or
Laser Therapy Journal of Neuro Interventional Surgery,
8: A74, 2016.
30- Xiaofan Pan and Dylan Wolman: Percutaneous bleomycin
foam effectively treats venous malformations. July 13,
2015.
31- Cooper A. and Kennedy M.W.: Biofoams and natural
protein surfactants. Biophys. Chem., 151: 96-104, 2010.
32- Zhang W., Chen G., Ren J.G., et al.: Bleomycin induces
endothelial mesenchymal transition through activation of
mTOR pathway: A possible mechanism contributing to
the sclerotherapy of venous malformations. Br. J. Pharmacol.,
170: 1210-20, 2013.
33- Huang Y., Li P., Xia S., et al.: Proapoptotic effect and the
mechanism of action of pingyangmycin on cavernous
hemangiomas. Exp. Ther. Med., 7: 473-7, 2014.
34- Mabeta P. and Davis P.F.: The mechanism of bleomycin
in inducing haemangioma regression. S Afr. Med. J., 98:
538-9, 2008.
408 Vol. 43, No. 3 / Effect of Foam & Liquid Bleomycin in the Management of Venous Malformations
35- Li P., Li D., Guo Z., et al.: Therapeutic mechanism of
bleomycin A5 on infancy hemangioma: an experimental
study. Zhonghua Kou Qiang Yi Xue Za Zhi, 48: 18-22,
2003.
36- Li P., Xiao X. and Guo Z.: Effect of bleomycin A5 on the
hemangioma-derived endothelial cell line XTPS-1. Zhonghua
Kou Qiang Yi Xue Za Zhi, 47: 324-8, 2012.
37- Yura J., Hashimoto T., Tsuruga N., et al.: Bleomycin
treatment for cystic hygroma in children. Nihon Geka
Hokan, 46: 607-14, 1977.
38- Tanigawa N., Shimomatsuya T., Takahashi L., et al.:
Treatment of cystic hygroma and lymphangioma with
the use of bleomycin fat emulsion. Cancer, 60: 741-9,
1987.
39- Muir T., Kirsten M., Fourie P., et al.: Intralesional Bleomycin
Injection (IBI) treatment for haemangiomas and
congenital vascular malformations. Pediatr. Surg. Int.,
19: 766-73, 2004.
40- Mathur N.N., Rana I., Bothra R., et al.: Bleomycin sclerotherapy
in congenital lymphatic and vascular malformations
of head and neck. Int. J. Pediatr. Otorhinolaryngol.,
69: 75-80, 2005.
41- Sainsbury D.C., Kessell G., Fall A.J., et al.: Intralesional
bleomycin injection treatment for vascular birthmarks: A
5-year experience at a single United Kingdom Unit. Plast.
Reconstr. Surg., 127: 2031-44, 2011.
42- Baskin D., Tander B. and Bankaoglu M.: Local bleomycin
injection in the treatment of lymphangioma. European
Journal of Pediatric Surgery: Official journal of Austrian
Association of Pediatric Surgery. [et al.]=Zeitschrift fur
Kinderchirurgie, 15: 383-6, 2005.
43- Mowad C.M., Nguyen T.V., Elenitsas R., et al.: Bleomycininduced
flagellate dermatitis: A clinical and histopathological
review. Br. J. Dermatol., 131: 700-02, 1994.
44- Sung M.W., Chang S.O., Choi J.H., et al.: Bleomycin
sclerotherapy in patients with congenital and lymphatic
malformation in the head and neck. Am. J. Otolaryngol.,
16: 236-41, 1995.
45- Gregorya S., Burrows P.E., Ellinas H., et al.: Combined
Nd: YAG laser and bleomycin sclerotherapy under the
same anesthesia for cervicofacial venous malformations:
A safe and effective treatment option. International Journal
of Pediatric Otorhinolaryngology, 108: 30-4, 2018.
46- Lee H.J., Kim T.W., Kim J.M., et al.: Percutaneous
sclerotherapy using bleomycin for the treatment of vascular
malformations. International Journal of Dermatology, 56:
1186-91, 2017.
47- Hou R., Guo J., Hu K., Yang Y., et al.: A clinical study
of ultrasound-guided intralesional injection of bleomycin
A5 on venous malformation in cervical-facial region in
China. J. Vasc. Surg., Vol. 51, 940-5, 2010